Introduction to the ninth edition: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
The Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines differs substantially from the prior versions both in process and in content. In this introduction, we describe some of the differences and the rationale for the changes.
Department of Clinical Epidemiology and Biostatistics, McMaster University Faculty of Health Sciences, Hamilton, ON, Canada; Department of Medicine, McMaster University Faculty of Health Sciences, Hamilton, ON, Canada. Electronic address: guyatt@mcmaster.ca.
Gordon H
GH
Guyatt
Department of Clinical Epidemiology and Biostatistics, McMaster University Faculty of Health Sciences, Hamilton, ON, Canada; Departments of Medicine and Family Medicine, State University of New York, Buffalo, NY.
Elie A
EA
Akl
Department of Medicine, McMaster University Faculty of Health Sciences, Hamilton, ON, Canada.
Mark
M
Crowther
Department of Clinical Epidemiology and Biostatistics, McMaster University Faculty of Health Sciences, Hamilton, ON, Canada; Department of Medicine, McMaster University Faculty of Health Sciences, Hamilton, ON, Canada.
Holger J
HJ
Schünemann
Cardiovascular Research Center, Medical College of Wisconsin, Milwaukee, WI.
David D
DD
Gutterman
Evidence-Based Clinical Practice Guidelines and Clinical Standards, American College of Chest Physicians, Northbrook, IL.
Sandra Zelman
SZ
Lewis
D016265:Conflict of Interest; D004059:Diffusion of Innovation; D019317:Evidence-Based Medicine; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D017410:Practice Guidelines as Topic; D012955:Societies, Medical; D013927:Thrombosis / Q000188:drug therapy* / Q000517:prevention & control*; D014481:United States
D005343:Fibrinolytic Agents